JBC Anatrace, Inc.

HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


Originally published In Press as doi:10.1074/jbc.M401643200 on April 1, 2004

J. Biol. Chem., Vol. 279, Issue 26, 26900-26905, June 25, 2004
This Article
Right arrow Abstract Freely available
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
279/26/26900    most recent
M401643200v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Matsushima, Y.
Right arrow Articles by Kaguni, L. S.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Matsushima, Y.
Right arrow Articles by Kaguni, L. S.
Social Bookmarking
 Add to CiteULike   Add to Complore   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?

Drosophila Mitochondrial Transcription Factor B2 Regulates Mitochondrial DNA Copy Number and Transcription in Schneider Cells*

Yuichi Matsushima{ddagger}, Rafael Garesse§, and Laurie S. Kaguni{ddagger}

From the {ddagger}Department of Biochemistry and Molecular Biology, Michigan State University, East Lansing, Michigan 48824-1319 and the §Departamento de Bioquímica, Instituto de Investigaciones Biomédicas Alberto Sols, Consejo Superior de Investigaciones Científicas-UAM, Facultad de Medicina, Universidad Autónoma de Madrid, c/Arzobispo Morcillo 4, 28029 Madrid, Spain

Received for publication, February 13, 2004 , and in revised form, March 31, 2004.


    ABSTRACT
 TOP
 ABSTRACT
 INTRODUCTION
 EXPERIMENTAL PROCEDURES
 RESULTS
 DISCUSSION
 REFERENCES
 
We report the cloning and molecular analysis of Drosophila mitochondrial transcription factor B2 (d-mt-TFB2), a protein that plays a role in mitochondrial transcription and mitochondrial DNA (mtDNA) replication in Drosophila. An RNA interference (RNAi) construct was designed that reduces expression of d-mtTFB2 to 5% of its normal level in Schneider cells. RNAi knock-down of d-mtTFB2 reduces the abundance of specific mitochondrial RNA transcripts 2- to 8-fold and decreases the copy number of mtDNA ~3-fold. In a corollary manner, we find that overexpression of d-mtTFB2 increases both the abundance of mitochondrial RNA transcripts and the copy number of mtDNA. In a comparative experiment, we find that overexpression of Drosophila mitochondrial transcription factor A (d-TFAM) increases mtDNA copy number with no significant effect on mitochondrial transcripts. This argues for a direct role for mtTFB2 in mitochondrial transcription and suggests that, if TFAM serves a role in transcription, its endogenous level limits mtDNA copy number but not transcription. Furthermore, we suggest that mtTFB2 increases mtDNA copy number by increasing the frequency of initiation of DNA replication, whereas TFAM serves to stabilize and package mtDNA in mitochondrial nucleoids. Our work represents the first study to document the function of mtTFB2 in vivo, establishing a dual role in regulation of both transcription and replication, and provides a benchmark for comparative biochemical studies in various animal systems.


    INTRODUCTION
 TOP
 ABSTRACT
 INTRODUCTION
 EXPERIMENTAL PROCEDURES
 RESULTS
 DISCUSSION
 REFERENCES
 
The mitochondria of eukaryotic cells utilize a number of organelle-specific factors in DNA and RNA metabolism. In Saccharomyces cerevisiae, mitochondrial transcription is mediated by the yeast mtRNA1 polymerase, Rpo41p (13), and a specificity factor Mtf1p (46), also known as mitochondrial transcription factor B (sc-mtTFB) (7). Deficiency in sc-mtTFB lowers the abundance of mitochondrial transcripts and reduces mtDNA copy number (5, 7). sc-mtTFB facilitates specific binding of mitochondrial RNA polymerase at numerous promoter sites in the yeast mitochondrial genome (4, 8, 9). Although sc-mtTFB is functionally similar to bacterial sigma factor (911), the two proteins do not share amino acid sequence (7, 12) or structural homology (13). Rather, the structure of sc-mtTFB is homologous to bacterial rRNA methyltransferases (13).

Mammalian mitochondrial transcription utilizes mitochondrial RNA polymerase, and three distinct transcription factors: transcription factor A (TFAM; formerly referred to as mtTFA) and two proteins homologous to sc-mtTFB, transcription factors mtTFB1 and mtTFB2 (3, 1417). TFAM contains two high mobility group boxes and was shown in organello to bind nonspecifically at regularly phased intervals to the control region of human mtDNA (18); it has recently been shown to package mtDNA in nucleoids (19, 20). h-TFAM was also shown to be required for specific initiation at mitochondrial promoters in vitro (1417). The yeast homologue of TFAM is Abf2p, an abundant protein whose primary role is to stabilize and compact mtDNA (2123); however, Abf2p is not required for transcription of yeast mtDNA (24). Both human mtTFB1 and mt-TFB2 have been shown to activate transcription from mitochondrial promoters in vitro, although their specific roles in mitochondrial transcription remain unclear (14, 15, 25). Recent studies indicate that h-mtTFB1 has rRNA methylase activity (26) and that its in vitro transcriptional activation and methylase activities can be differentially inactivated by mutation (25).

Functional studies of the three animal mitochondrial transcription factors in vivo are very limited, and to date, only studies of TFAM have been reported. Gene-targeted disruption of mouse TFAM results in loss of mtDNA (27), and its overexpression in chicken DT40 cells increases the copy number of mtDNA (28). Depletion of Drosophila TFAM in cell culture by double-stranded RNAi results in a marked reduction of mtDNA content, without significant inhibition of mitochondrial transcription (29). Taken together, these physiological data support an important role for TFAM in mtDNA maintenance.

Here, we report the cloning and overexpression of Drosophila mtTFB2, and the knock-down phenotype of Drosophila Schneider cells treated with d-mtTFB2-targeted RNAi. Our results argue strongly that d-mtTFB2 is required both for efficient mitochondrial transcription and for maintenance of mtDNA.


    EXPERIMENTAL PROCEDURES
 TOP
 ABSTRACT
 INTRODUCTION
 EXPERIMENTAL PROCEDURES
 RESULTS
 DISCUSSION
 REFERENCES
 
Identification and Sequence Analysis of d-mtTFB2 cDNA—The amino acid sequence of d-mtTFB1 was used to search the Berkeley Drosophila Genome Project database. One sequence (CG3910) was identified that has a high level of homology to d-mtTFB1. Full-length cDNA was prepared using the SMART RACE cDNA amplification kit (Clontech), total RNA from Drosophila Schneider S2 cells, and the following primers: 5'-TTACCCAACTTGCTACTCTTGGTGG-3' and 5'-GGGCTCGAGGCACCTTGGCTATGAATTTGTGCTC-3' for 5' RACE, and 5'-CAAAATGGACGGTGGTTCCAGG-3' and 5'-GGGGAATTCCTTCAAGCACTTGATCAACTCC-3' for 3' RACE. RACE products were purified from an agarose gel and sequenced, and sequence analysis was performed using MacDNASIS version 3.7 (Hitachi Software). Similarity searches against the nonredundant GenBankTM data base were performed using BLAST (30). The deduced amino acid sequence was checked for targeting signal peptides using iPSORT (31) and MITPROT (32). Multiple sequence alignments were performed with ClustalW (33).

Bacterial Overexpression of d-mtTFB2 and Preparation of d-mtTFB2 Antibody—To express d-mtTFB2 in Escherichia coli, a PCR fragment of d-mtTFB2 cDNA encoding amino acid residues Ala-13 to Ser-252 was cloned into pET-28a (Novagen) cleaved with BamHI and EcoRI. Bacterial cells harboring the plasmid were grown in LB medium containing 100 µg/ml kanamycin, and expression was induced with 1 mM isopropylthiogalactoside. The C-terminal hexahistidine tag was utilized for nickel-nitrilotriacetic acid affinity purification of recombinant d-mt-TFB2 according to the manufacturer's instructions (Qiagen). Rabbits were immunized by injection of column-purified d-mtTFB2 in Freund's complete adjuvant, followed by secondary immunization in Freund's incomplete adjuvant. To prepare affinity-purified antiserum, purified d-mtTFB2 (100 µg) was bound to a polyvinylidene difluoride membrane, and the filter was preincubated for 1 h with 5% skim milk in PBS, incubated for 1 h with crude antiserum (1 ml in 5 ml of PBS containing 0.1% Tween 20), washed four times with PBS containing 0.1% Tween 20, and eluted with 0.2 M glycine-HCl, pH 2.4 (~5 ml). The eluted antibody was neutralized with 1 M Tris base.

Preparation of Inducible Plasmids Expressing d-mtTFB2-, d-TFAM-, and d-mtTFB2-targeted RNAi—The plasmid pMt/mtTFB2/Hy, in which d-mtTFB2 cDNA is regulated by the metallothionein promoter, was constructed as follows: a fragment of d-mtTFB2 cDNA was amplified by PCR using as 5'-primer 5'-GGGCTCGAGAAAAATCTTAAGAAATGCTG-3' and as 3'-primer 5'-GCGCACTAGTCTAAGAACTGGCTTTCCTG-3'. The PCR fragment was cleaved by XhoI and EcoRI and subcloned. The plasmid pMt/TFAM/Hy, in which d-TFAM cDNA is regulated by the metallothionein promoter, was constructed as follows: a fragment of d-TFAM cDNA was amplified by PCR using as 5'-primer 5'-GGGCTCGAGCAGGTTCGCCATTGAGATC-3' and as 3'-primer 5'-GCGCACTAGTGTGAATTATGTGATGGAAGAG-3'. The PCR fragment was cleaved by XhoI and SpeI and subcloned. The plasmid pMt/invB2/Hy carries an inverted repeat of a nucleotide sequence from d-mtTFB2 cDNA that is transcribed from the metallothionein promoter. The insert in pMt/invB2/Hy was generated from two PCR-amplified fragments of d-mtTFB2 cDNA. One fragment has terminal XhoI and EcoRI sites and was prepared using the following pair of primers: 5'-GCGCCTCGAGACTAGTAAGGTGCAGTCCATCAATCC-3' (forward) and 5'-GCGCGAATTCGGGATCGATTAGCGTCAGAATCTGACTGG-3' (reverse). A second fragment has terminal SpeI and EcoRI sites and was prepared using the primers 5'-GCGCCTCGAGACTAGTAAGGTGCAGTCCATCAATCC-3' (forward) and 5'-GCGCGAATTCAAAAAGCTTTAGCGTCAGAATCTGACTGG-3' (reverse). The two PCR products were ligated and cloned into the pMt/Hy vector cleaved with XhoI and SpeI.

Generation and Induction of Stable Cell Lines—Drosophila Schneider S2 cells were cultured at 25 °C in Drosophila Schneider Medium (Invitrogen) supplemented with 10% fetal bovine serum, with the exception of the uninduced culture carrying the overexpression construct oexB2, which was grown in the presence of 0.5% fetal bovine serum to suppress leaky expression from the metallothionein promoter (see Fig. 5, lane 5). Cells were subcultured to 3 x 106 cells/ml every third day. Cells were transfected using Effecten (Qiagen). Hygromycin-resistant cells were selected with 200 µg/µl hygromycin. Cells were passaged at least five times in hygromycin-containing medium and then cultured in standard medium. The cell lines were grown to a density of 3 x 106/ml and then treated with 0.4 mM CuSO4 to induce high level expression from the metallothionein promoter (34). Low level expression was effected by growth of cell cultures in the presence of 0.04 mM CuSO4 (see Fig. 6).



View larger version (43K):
[in this window]
[in a new window]
 
FIG. 5.
mtRNA and mtDNA abundance in Schneider cells overexpressing d-mtTFB2. Schneider cells (control) or Schneider cells carrying pMt/Hy (vector) or pMt/mtTFB2/Hy (oexB2) were grown for 10 days in the presence or absence of 0.4 mM CuSO4. A, immunoblot analysis of d-mtTFB2 and Drosophila pol {gamma}-{alpha} was carried out as described in the legend to Fig. 2B. B, Northern blot analysis using probes for 12S rRNA, ND4, Cytb, and Rp49 was carried out as described in the legend to Fig. 3. C, Southern blots were probed with radiolabeled mtDNA probe (top panel) or control probe (lower panel). mtDNA abundance was determined as described in legend to Fig. 4.

 



View larger version (42K):
[in this window]
[in a new window]
 
FIG. 6.
mtRNA and mtDNA abundance in Schneider cells overexpressing d-TFAM or d-mtTFB2. Schneider cells (control) or Schneider cells carrying pMt/TFAM/Hy (oexA) (A–C) or pMt/mt-TFB2/Hy (oexB2) (D–F) were grown for 10 days under low level induction conditions as described under "Experimental Procedures." A and D, immunoblot analysis of d-TFAM and d-mtTFB2 was carried out as described in the legend to Fig. 2B. B and E, Northern blot analysis using probes for 12S rRNA, ND4, Cytb, and Rp49 was carried out as described in the legend to Fig. 3. C and F, Southern blots were probed with radiolabeled mtDNA probe (top panel) or control probe (lower panel). mtDNA abundance was determined as described in legend to Fig. 4.

 
Immunoblotting—Total cellular protein (20 µg per lane) was fractionated by 10.5% SDS-PAGE and transferred to nitrocellulose filters. Filters were preincubated for 1 h with 5% skim milk in PBS, followed by incubation for 1 h with d-mtTFB2 antibody (1:25 ml in PBS containing 0.1% Tween 20). Filters were washed four times with PBS containing 0.1% Tween 20, incubated for 1 h with horseradish peroxidase-conjugated anti-rabbit IgG (BIO-RAD), and washed with PBS containing 0.1% Tween 20. Protein bands were visualized using ECL Western blotting reagents (Amersham Biosciences). Polyclonal antibody against Drosophila TFAM was prepared and used as described in a previous study (29).

Northern and Southern Blotting—Total cellular RNA was extracted using TRIzol reagent (Amersham Biosciences). RNA (5 µg per lane) was fractionated in a 1.2% agarose/formaldehyde gel, blotted onto a Hybond-N+ nylon membrane (Amersham Biosciences), and hybridized to 32P-labeled probes for each of the following four genes: ribosomal protein 49 (Rp49), cytochrome b (Cytb), NADH dehydrogenase subunit 4 (ND4), or 12S rRNA. Hybridization was carried out for 16 h at 42 °C in 5x SSPE (150 mM NaCl/10 mM sodium phosphate, pH 7.4/1 mM EDTA), 0.5% SDS, 5x Denhardt's solution, and 50% formamide. The membrane was washed twice at room temperature with 2x SSC containing 0.1%, and twice with 0.1x SSC containing 0.1% SDS for 30 min at 55 °C, and then analyzed with a PhosphorImager (Amersham Biosciences). The signal for RP49 was used to normalize mitochondrial transcripts.

Genomic DNA was purified from Drosophila Schneider S2 cells by standard methods. DNA (5 µg per lane) was cleaved with XhoI, fractionated in a 0.8% agarose gel/TBE and transferred to nylon membrane (Amersham Biosciences). Hybridization was performed as above. Filters were washed three times for 10 min at room temperature with 2x SSC containing 0.1% SDS, once for 30 min at 65 °C with 0.2x SSC containing 0.1% SDS, and then analyzed with a PhosphorImager (Amersham Biosciences). Blots were probed with radiolabeled DNAs for the mitochondrial gene Cytb and the nuclear histone gene cluster. The ratio of the signals for these two genes was used to estimate the relative copy number of mtDNA.


    RESULTS
 TOP
 ABSTRACT
 INTRODUCTION
 EXPERIMENTAL PROCEDURES
 RESULTS
 DISCUSSION
 REFERENCES
 
Cloning of Drosophila melanogaster mtTFB2—Two conserved proteins, h-mtTFB1 and h-mtTFB2, function in human mitochondrial transcription in vitro (14, 15, 25). The sequence of a putative d-mtTFB1 (14) was used to search the Berkeley Drosophila Genome Project database for a Drosophila homologue of h-mtTFB2. The search identified a predicted protein, CG3910, whose nucleotide sequence was used to identify and clone a full-length cDNA by rapid amplification of cDNA ends (RACE). The cDNA clone obtained is 1506 nucleotides and encodes a predicted polypeptide of 452 amino acids. Protein sequence analysis with MitoProt II and iPSORT indicate a high probability of mitochondrial localization via a 30-amino acid N-terminal mitochondrial targeting peptide, with the full-length and processed forms of d-mtTFB2 predicted to be 52.2 and 48.6 kDa, respectively. d-mtTFB2 was found to be 34% homologous to human mtTFB2 and 36% homologous to mouse mtTFB2 (Fig. 1). As was shown previously (15), we found bacterial rRNA methyltransferase to be a member of the same protein family (data not shown).



View larger version (85K):
[in this window]
[in a new window]
 
FIG. 1.
Alignment of Drosophila mt-TFB2 with mouse and human homologues. Conserved residues are indicated by inverse font. Residues similar to d-mt-TFB2 are highlighted with gray.

 
Rabbit antiserum was raised against a recombinant, truncated form of d-mtTFB2 (Ala-13 to Ser-252). The antibody detects a single polypeptide in protein extracts from Drosophila Schneider cells with an electrophoretic mobility corresponding to an approximate molecular mass of 50 kDa (Fig. 2A). Immunoblot analysis of subcellular fractions of Drosophila Schneider cells demonstrated that d-mtTFB2 is localized to the mitochondria (data not shown).



View larger version (22K):
[in this window]
[in a new window]
 
FIG. 2.
Expression of d-mtTFB2-targeted RNAi in Schneider cells. A, immunoblot analysis of Schneider cell extract probed with affinity-purified rabbit antiserum against d-mtTFB2. B, Schneider cells with no plasmid (control) or carrying pMt/Hy (vector) or pMt/invB2/Hy (RNAiB2) were cultured for 10 days in the presence or absence of 0.4 mM CuSO4. Protein extracts (20 µg) were fractionated by 10.5% SDS-PAGE, transferred to nitrocellulose filters, and probed with rabbit antiserum against d-mtTFB2 or Drosophila pol {gamma}-{alpha} as indicated.

 
RNAi-dependent Knock-down of d-mtTFB2 Reduces Cell Growth and Mitochondrial Transcription and Induces mtDNA Depletion—The abundance of d-mtTFB2 was reduced by expressing a metallothionein-inducible d-mtTFB2-targeted RNAi species (3537) from the plasmid pMt/invB2/Hy. The RNA species produced forms a dsRNA hairpin homologous to d-mt-TFB2. Previous studies indicate that dsRNA hairpins are efficient RNAi inhibitors (3840).

Cells stably expressing pMt/invB2/Hy or the control plasmid pMt/Hy were cultured for 10 days in the absence or presence of 0.4 mM CuSO4. Immunoblot analysis of copper-treated cells showed that cells carrying pMt/invB2/Hy expressed 20-fold less d-mtTFB2 than cells carrying the control vector (Fig. 2B). Basal, uninduced expression from pMt/invB2/Hy (which results from metal contamination in the fetal bovine serum, see "Experimental Procedures") also suppressed expression of d-mtTFB2 by 5-fold. In contrast, expression of the catalytic subunit of Drosophila mitochondrial DNA polymerase, pol {gamma}-{alpha}, was unchanged under all four experimental conditions. Furthermore, the level of transcripts from d-mtTFB1 was unchanged by d-mtTFB2-targeted RNAi (data not shown). Likewise, copper-treated cells carrying pMt/invB2/Hy grew poorly and demonstrated reduced viability, but copper treatment had no adverse effects on growth of control cells (data not shown).

The biological function of d-mtTFB2 was examined in cells expressing d-mtTFB2-targeted RNAi. Transcription of several mitochondrial genes and mtDNA copy number were measured in cells carrying no plasmid, pMt/Hy or pMt/invB2/Hy. Northern blots were used to quantitate relative expression of the Cytb, ND4, and 12S rRNA genes in cells grown for 10 days in the presence or absence of copper. Basal expression of d-mt-TFB2-targeted RNAi reduced the transcript levels for Cytb, ND4, and 12S rRNA to 61%, 34%, and 70% of their level in control cells, respectively (Fig. 3); after induction in the presence of copper, transcript levels were further reduced to 13%, 16%, and 57% of control cells, respectively. In contrast, the level of transcripts from the nuclear gene RP49 was unchanged by d-mtTFB2-targeted RNAi. These results show that d-mt-TFB2 is critical for transcription of both strands of Drosophila mtDNA, because Cytb is encoded on the opposite strand from ND4 and 12S rRNA.



View larger version (34K):
[in this window]
[in a new window]
 
FIG. 3.
Effects of RNAi on the level of mitochondrial transcription. A, total RNA (5 µg) was extracted from Schneider cells (control) or Schneider cells carrying pMt/Hy (vector) or pMt/invB2/Hy (RNAiB2) after 10 days of culture in the presence or absence of 0.4 mM CuSO4. RNA was fractionated in a 1.2% agarose/formaldehyde gel, blotted to nylon membrane, and hybridized with radiolabeled probes for the mitochondrial transcripts 12S rRNA, ND4, and Cytb and the nuclear transcript Rp49. B, relative transcription efficiency was quantitated by normalizing mitochondrial transcript abundance to that of Rp49.

 
The copy number of mtDNA was also reduced in cells expressing d-mtTFB2-targeted RNAi. Total cellular DNA was isolated from cells carrying no plasmid, pMt/Hy or pMt/invB2/Hy, cleaved with XhoI, and analyzed by Southern blot. Blots were hybridized sequentially with probes for the nuclear histone gene cluster and for the mitochondrial gene CytB (Fig. 4A). Relative mtDNA copy number was estimated from the ratio of CytB hybridization to histone cluster hybridization (Fig. 4B). After induction of d-mtTFB2-targeted RNAi for 10 days, relative mtDNA copy number was 38% of the control; without induction, the basal level of d-mtTFB2-targeted RNAi reduced the mtDNA copy number to 64% of control. This result suggests that d-mtTFB2 is also required for synthesis of RNA primers during replication of mtDNA.



View larger version (17K):
[in this window]
[in a new window]
 
FIG. 4.
Effect of RNAi on the copy number of mtDNA. A, total DNA (5 µg) was isolated from control Schneider cells (control) or Schneider cells carrying pMt/Hy (vector) or pMt/invB2/Hy (RNAiB2) after 10 days culture with or without 0.4 mM CuSO4. DNA was digested with XhoI, fractionated in a 0.7% agarose/TBE gel, and blotted to nylon membrane. The membrane was hybridized with radiolabeled probe for the histone gene cluster (control) and then stripped and re-hybridized with radiolabeled probe for Cytb. B, relative mtDNA copy number was estimated as described under "Experimental Procedures."

 
Overexpression of d-mtTFB2 Increases Mitochondrial Transcription and mtDNA Copy Number—d-mtTFB2 was subcloned into the inducible expression vector pMt/Hy under the control of the metallothionein promoter. The resulting expression vector, pMt/mtTFB2/Hy, was introduced into Schneider cells, and stable cell lines harboring this plasmid were cultured in media with or without 0.4 mM CuSO4. After 10 days of incubation in the presence of copper, immunoblot analysis indicated a 40-fold increase in d-mtTFB2 relative to that in the uninduced control (Fig. 5A). Drosophila pol {gamma}-{alpha} was not overexpressed under the same conditions. In contrast to the deleterious effect of reduced expression of d-mtTFB2, overexpression had no effect on cell growth or viability (data not shown). The effect of d-mtTFB2 overexpression on mitochondrial transcript abundance was evaluated by Northern blots. Blots were probed for transcripts from the mitochondrial ND4, Cytb, and 12S rRNA genes and for nuclear RP49 as a control (Fig. 5B). The results demonstrate that the level of all three mitochondrial RNA transcripts increases ~2-fold in cells that overexpress d-mtTFB2, whereas the level of nuclear RP49 transcript is unchanged. Relative copy number of mtDNA was also increased ~2-fold in cells that overexpress d-mtTFB2 (Fig. 5C).

Functional Differences between d-TFAM and d-mtTFB2 in Mitochondrial Regulation—To compare the roles of d-TFAM and d-mtTFB2 in mitochondrial regulation, we established a cell line that expresses d-TFAM under the control of the metallothionein promoter. After 10 days of low level induction in the absence and presence of 0.04 mM CuSO4, immunoblot analysis indicated 1.5- and 2.6-fold increases in d-TFAM, respectively, relative to the control, with no significant change in the level of d-mtTFB2 (Fig. 6A). The effect of d-TFAM overexpression on mitochondrial transcript abundance was evaluated by Northern blots. Blots were probed for transcripts from the mitochondrial ND4, Cytb, and 12S rRNA genes and for nuclear RP49 as a control (Fig. 6B). The results demonstrate that the level of all three mitochondrial transcripts is unchanged, arguing that endogenous levels of d-TFAM are in excess of that required for its role in transcription, if any. In contrast, the relative copy number of mtDNA was increased by 1.5- and 1.9-fold, corresponding directly with the 1.5- and 2.6-fold increases in d-TFAM, respectively (Fig. 6C). By comparison, after 10 days of low level induction of d-mtTFB2, immunoblot analysis indicated 1.6- and 5-fold increases in d-mtTFB2 relative to the control (Fig. 6D), with no significant change in the level of d-TFAM. However, d-mtTFB2 overexpression resulted in both corresponding increases in mitochondrial transcripts in the range of 1.3- to 1.4-fold and 2.1- to 2.2-fold (Fig. 6E) and in mtDNA copy number of 1.2- and 2.1-fold (Fig. 6F), at the two elevated levels of d-mtTFB2, respectively.


    DISCUSSION
 TOP
 ABSTRACT
 INTRODUCTION
 EXPERIMENTAL PROCEDURES
 RESULTS
 DISCUSSION
 REFERENCES
 
Drosophila mtTFB2 shares homology with human mtTFB2 that has been shown to be important for mitochondrial transcription in vitro (15). In Drosophila Schneider cells treated with RNAi, d-mtTFB2 is expressed at 5% of the endogenous level and induces cellular phenotypes of slow growth, reduced viability, 2- to 8-fold reduction in abundance of specific mitochondrial transcripts, and 3-fold reduction in mtDNA copy number. Overexpression of d-mtTFB2 modestly stimulates transcription of mitochondrial genes and increases mtDNA copy number 2-fold. These data provide the first evidence that animal mtTFB2 plays an important role in both mitochondrial transcription and mtDNA replication in vivo.

We found that mitochondrial transcript levels depend both on the abundance of d-mtTFB2 and on the specific mitochondrial gene examined. Basal-level expression of RNAi in Schneider cells was sufficient to reduce 4-fold the level of d-mtTFB2, whereas its induced expression reduced d-mtTFB2 levels by 20-fold. By comparison, mitochondrial mRNA abundance was reduced 1.6- to 3-fold under basal conditions and 6- to 8-fold under induced conditions. Under both induced and uninduced conditions, the level of the 12S rRNA transcript was substantially less sensitive to the abundance of d-mtTFB2 than were the levels of two mRNA species. The reason for this pattern is not clear, but it may indicate a faster turnover of mitochondrial mRNA as compared with mitochondrial rRNA (41). Although information on transcriptional mechanism in Drosophila remains limited, several polycistronic transcripts were identified and mapped by Berthier et al. (42), suggesting that Drosophila mtDNA is transcribed polycistronically as in other organisms, and similar to mammals, mitochondrial rRNAs were found to be more abundant than mRNAs (42). Recently, Drosophila mitochondrial transcription termination factor was identified that mediates termination of transcription of the ribosomal unit, accounting for the excess production of mitochondrial rRNAs (43). Overall, we found that mRNA levels were reduced more than the levels of mtDNA, and this, too, may reflect a higher turnover rate for mRNAs as compared with that of mtDNA. Interestingly, a similar result was obtained in an RNA knock-down analysis of mitochondrial RNA polymerase in trypanosomes (44). In any case, because of the differential effects we observed on mtDNA copy number and transcription in the overexpression analyses of d-mtTFB2 and d-TFAM, it is apparent that the effect of d-mtTFB2 on transcription is not a simple consequence of mtDNA dose.

We found that the abundance of d-mtTFB2 influences modestly the efficiency of mtDNA replication, where 2- to 3-fold effects were observed over a broad range of 20-fold underexpression to 40-fold overexpression. In human and mouse cells, initiation of mtDNA replication was proposed to involve synthesis of an RNA primer by transcription from the light strand promoter, followed by RNA processing and then extension of the RNA primer by DNA polymerase {gamma} in a unidirectional and strand asymmetric manner (45, 46). Our study suggests that d-mTFB2 is involved in the synthesis of RNA primer(s) for mtDNA replication, because mtDNA copy number changes in parallel with both increasing and decreasing the levels of d-mtTFB2, and this is accompanied by corresponding changes in mitochondrial transcripts.

Relatively little is known about the mechanism of mtDNA replication in Drosophila (47), and new experimental approaches have led to a reconsideration of the long standing model proposed for mouse and man (4850). In the recent model, mtDNA replication is proposed to initiate bidirectionally within a broad zone and proceed symmetrically, becoming unidirectional when one fork encounters a barrier in the vicinity of the previously designated leading strand origin (5153). In considering both models, it remains possible that only one primer is made for leading and one for lagging DNA strand synthesis, or that multiple primers are synthesized on one or both DNA strands. Whatever the case, our data would suggest that at least one of these is made by mtRNA polymerase functioning together with d-mTFB2, either at a promoter or elsewhere. Because we find d-mTFB2 abundance regulates mtDNA copy number, we would suggest that this priming event is likely critical to initiation of mtDNA replication.

In vitro studies show that both mtTFB1 and mtTFB2 support transcription from human mitochondrial promoters (15), but their relative importance and specific roles are not well understood. That RNAi knock-down of d-mtTFB2 lowers the efficiency of mitochondrial transcription in Drosophila-cultured cells is particularly significant, because the data argue strongly that endogenous mtTFB1 cannot complement a deficiency in mtTFB2. Thus, mtTFB1 is not functionally redundant with mtTFB2, pointing to specialized roles for the two transcription factors in vivo. In this regard, it has been reported that h-mtTFB1 has rRNA methyltransferase activity (26) and that h-mtTFB2 is at least one order of magnitude more active in promoting transcription in vitro than h-mtTFB1 (15).

The physiological role of TFAM in mitochondrial transcription is less clear. Our data show that overexpression of d-TFAM increases mtDNA copy number without increasing mitochondrial transcripts, consistent with the finding of Kitagawa and colleagues (29), who showed that deficiency of d-TFAM reduces markedly mtDNA copy number without significant inhibition of mitochondrial transcription in Drosophila cultured cells. One possible explanation for these results is that the endogenous level of d-TFAM is in excess of that needed for mitochondrial transcription but limits mtDNA copy number, such that its residual level upon RNA knock-down is sufficient to support constitutive levels of transcription but is insufficient for mtDNA maintenance. In this regard, recent studies show that the h-TFAM:mtDNA ratio is 1700:1 in human HeLa cells (54), yet it fully activates promoter-specific transcription in the presence of either h-mtTFB1 or B2 in vitro at a level corresponding to a h-TFAM:DNA template ratio of 10–100:1 (15). An alternate explanation is that, in Drosophila mitochondrial transcription, d-TFAM does not function together with d-mtTFB2 (or B1), reminiscent of the case in yeast, in which Abf2p (sc-TFAM), which is required for mtDNA stability and packaging (21, 55), is not required for transcription of yeast mtDNA (24). In any case, our data suggest differential roles for mtTFB2 and TFAM in mtDNA maintenance, with mtTFB2 regulating the frequency of initiation of replication and TFAM stabilizing and packaging mtDNA via dynamic, histone-like interactions in mitochondrial nucleoids. Clearly, more detailed physiological and biochemical studies are needed to understand the mechanisms of mitochondrial transcription, mtDNA replication, and the regulation of mitochondrial biogenesis. Such studies will help to differentiate the functional roles of the three animal mitochondrial transcription factors.


    FOOTNOTES
 
* This work was supported by National Institutes of Health Grant GM45295 (to L. S. K.) and by Ministerio de Ciencia y Tecnologia, Spain (Grant BMC01-1525 to R. G.). The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. Section 1734 solely to indicate this fact. Back

To whom correspondence should be addressed: Dept. of Biochemistry and Molecular Biology, Michigan State University, East Lansing, Michigan 48824-1319. Tel.: 517-353-6703; Fax: 517-353-9334; E-mail: lskaguni{at}msu.edu.

1 The abbreviations used are: mtRNA, mitochondrial RNA; mtTFB1, mt transcription factor B1; mtTFB2, mt transcription factor B2; TFAM, mt transcription factor A; h-, human; d-, Drosophila; sc-, Saccharomyces cerevisiae; RACE, rapid amplification of cDNA ends; RNAi, RNA interference; Rp49, ribosomal protein 49; Cytb, cytochrome b; ND4, NADH dehydrogenase subunit 4; PBS, phosphate-buffered saline. Back


    ACKNOWLEDGMENTS
 
We thank Carol Farr for assistance with the figures.



    REFERENCES
 TOP
 ABSTRACT
 INTRODUCTION
 EXPERIMENTAL PROCEDURES
 RESULTS
 DISCUSSION
 REFERENCES
 

  1. Masters, B. S., Stohl, L. L., and Clayton, D. A. (1987) Cell 51, 89–99[CrossRef][Medline] [Order article via Infotrieve]
  2. Jaehning, J. A. (1993) Mol. Microbiol. 8, 1–4[Medline] [Order article via Infotrieve]
  3. Shadel, G. S., and Clayton, D. A. (1993) J. Biol. Chem. 268, 16083–16086[Free Full Text]
  4. Schinkel, A. H., Groot Koerkamp, M. J., and Tabak, H. F. (1988) EMBO J. 7, 3255–3262[Medline] [Order article via Infotrieve]
  5. Lisowsky, T., and Michaelis, G. (1989) Mol. Gen. Genet. 219, 125–128[Medline] [Order article via Infotrieve]
  6. Jang, S. H., and Jaehning, J. A. (1991) J. Biol. Chem. 266, 22671–22677[Abstract/Free Full Text]
  7. Shadel, G. S., and Clayton, D. A. (1995) Mol. Cell. Biol. 15, 2101–2108[Abstract]
  8. Schinkel, A. H., Koerkamp, M. J., Touw, E. P., and Tabak, H. F. (1987) J. Biol. Chem. 262, 12785–12791[Abstract/Free Full Text]
  9. Mangus, D. A., Jang, S. H., and Jaehning, J. A. (1994) J. Biol. Chem. 269, 26568–26574[Abstract/Free Full Text]
  10. Cliften, P. F., Park, J. Y., Davis, B. P., Jang, S. H., and Jaehning, J. A. (1997) Genes Dev. 11, 2897–2909[Abstract/Free Full Text]
  11. Cliften, P. F., Jang, S. H., and Jaehning, J. A. (2000) Mol. Cell. Biol. 20, 7013–7023[Abstract/Free Full Text]
  12. Carrodeguas, J. A., Yun, S., Shadel, G. S., Clayton, D. A., and Bogenhagen, D. F. (1996) Gene Expr. 6, 219–230[Medline] [Order article via Infotrieve]
  13. Schubot, F. D., Chen, C. J., Rose, J. P., Dailey, T. A., Dailey, H. A., and Wang, B. C. (2001) Protein Sci. 10, 1980–1988[Abstract/Free Full Text]
  14. McCulloch, V., Seidel-Rogol, B. L., and Shadel, G. S. (2002) Mol. Cell. Biol. 22, 1116–1125[Abstract/Free Full Text]
  15. Falkenberg, M., Gaspari, M., Rantanen, A., Trifunovic, A., Larsson, N. G., and Gustafsson, C. M. (2002) Nat. Genet. 31, 289–294[CrossRef][Medline] [Order article via Infotrieve]
  16. Parisi, M. A., and Clayton, D. A. (1991) Science 252, 965–969[Abstract/Free Full Text]
  17. Fisher, R. P., Topper, J. N., and Clayton, D. A. (1987) Cell 50, 247–258[CrossRef][Medline] [Order article via Infotrieve]
  18. Ghivizzani, S. C., Madsen, C. S., Nelen, M. R., Ammini, C. V., and Hauswirth, W. W. (1994) Mol. Cell. Biol. 14, 7717–7730[Abstract/Free Full Text]
  19. Alam, T. I., Kanki, T., Muta, T., Ukaji, K., Abe, Y., Nakayama, H., Takio, K., Hamasaki, N., and Kang, D. (2003) Nucleic Acids Res. 31, 1640–1645[Abstract/Free Full Text]
  20. Garrido, N., Griparic, L., Jokitalo, E., Wartiovaara, J., van der Bliek, A. M., and Spelbrink, J. N. (2003) Mol. Biol. Cell 14, 1583–1596[Abstract/Free Full Text]
  21. Fisher, R. P., Lisowsky, T., Parisi, M. A., and Clayton, D. A. (1992) J. Biol. Chem. 267, 3358–3367[Abstract/Free Full Text]
  22. Diffley, J. F., and Stillman, B. (1992) J. Biol. Chem. 267, 3368–3374[Abstract/Free Full Text]
  23. Diffley, J. F., and Stillman, B. (1991) Proc. Natl. Acad. Sci. U. S. A. 88, 7864–7868[Abstract/Free Full Text]
  24. Xu, B., and Clayton, D. A. (1992) Nucleic Acids Res. 20, 1053–1059[Abstract/Free Full Text]
  25. McCulloch, V., and Shadel, G. S. (2003) Mol. Cell. Biol. 23, 5816–5824[Abstract/Free Full Text]
  26. Seidel-Rogol, B. L., McCulloch, V., and Shadel, G. S. (2003) Nat. Genet. 33, 23–24[CrossRef][Medline] [Order article via Infotrieve]
  27. Larsson, N. G., Wang, J., Wilhelmsson, H., Oldfors, A., Rustin, P., Lewandoski, M., Barsh, G. S., and Clayton, D. A. (1998) Nat. Genet. 18, 231–236[CrossRef][Medline] [Order article via Infotrieve]
  28. Matsushima, Y., Matsumura, K., Ishii, S., Inagaki, H., Suzuki, T., Matsuda, Y., Beck, K., and Kitagawa, Y. (2003) J. Biol. Chem. 278, 31149–31158[Abstract/Free Full Text]
  29. Goto, A., Matsushima, Y., Kadowaki, T., and Kitagawa, Y. (2001) Biochem. J. 354, 243–248[CrossRef][Medline] [Order article via Infotrieve]
  30. Altschul, S. F., Gish, W., Miller, W., Myers, E. W., and Lipman, D. J. (1990) J. Mol. Biol. 215, 403–410[CrossRef][Medline] [Order article via Infotrieve]
  31. Horton, P., and Nakai, K. (1997) Proc. Int. Conf. Intell. Syst. Mol. Biol. 5, 147–152[Medline] [Order article via Infotrieve]
  32. Claros, M. G., and Vincens, P. (1996) Eur. J. Biochem. 241, 779–786[Medline] [Order article via Infotrieve]
  33. Thompson, J. D., Higgins, D. G., and Gibson, T. J. (1994) Nucleic Acids Res. 22, 4673–4680[Abstract/Free Full Text]
  34. Bunch, T. A., Grinblat, Y., and Goldstein, L. S. (1988) Nucleic Acids Res. 16, 1043–1061[Abstract/Free Full Text]
  35. Hammond, S. M., Bernstein, E., Beach, D., and Hannon, G. J. (2000) Nature 404, 293–296[CrossRef][Medline] [Order article via Infotrieve]
  36. Baulcombe, D. C. (1999) Curr. Biol. 9, R599–R601[CrossRef][Medline] [Order article via Infotrieve]
  37. Kennerdell, J. R., and Carthew, R. W. (1998) Cell 95, 1017–1026[CrossRef][Medline] [Order article via Infotrieve]
  38. Lam, G., and Thummel, C. S. (2000) Curr. Biol. 10, 957–963[CrossRef][Medline] [Order article via Infotrieve]
  39. Kennerdell, J. R., and Carthew, R. W. (2000) Nat. Biotechnol. 18, 896–898[CrossRef][Medline] [Order article via Infotrieve]
  40. Tavernarakis, N., and Driscoll, M. (2000) J. Neurogenet. 13, 257–264[Medline] [Order article via Infotrieve]
  41. Gelfand, R., and Attardi, G. (1981) Mol. Cell. Biol. 1, 497–511[Abstract/Free Full Text]
  42. Berthier, F., Renaud, M., Alziari, S., and Durand, R. (1986) Nucleic Acids Res. 14, 4519–4533[Abstract/Free Full Text]
  43. Roberti, M., Polosa, P. L., Bruni, F., Musicco, C., Gadaleta, M. N., and Cantatore, P. (2003) Nucleic Acids Res. 31, 1597–1604[Abstract/Free Full Text]
  44. Grams, J., Morris, J. C., Drew, M. E., Wang, Z., Englund, P. T., and Hajduk, S. L. (2002) J. Biol. Chem. 277, 16952–16959[Abstract/Free Full Text]
  45. Clayton, D. A. (1982) Cell 28, 693–705[CrossRef][Medline] [Order article via Infotrieve]
  46. Shadel, G. S., and Clayton, D. A. (1997) Annu. Rev. Biochem. 66, 409–435[CrossRef][Medline] [Order article via Infotrieve]
  47. Goddard, J. M., and Wolstenholme, D. R. (1978) Proc. Natl. Acad. Sci. U. S. A. 75, 3886–3890[Abstract/Free Full Text]
  48. Holt, I. J., and Jacobs, H. T. (2003) Trends Biochem. Sci. 28, 355–356[CrossRef][Medline] [Order article via Infotrieve]
  49. Bogenhagen, D. F., and Clayton, D. A. (2003) Trends Biochem. Sci. 28, 357–360[CrossRef][Medline] [Order article via Infotrieve]
  50. Bogenhagen, D. F., and Clayton, D. A. (2003) Trends Biochem. Sci. 28, 404–405[CrossRef][Medline] [Order article via Infotrieve]
  51. Holt, I. J., Lorimer, H. E., and Jacobs, H. T. (2000) Cell 100, 515–524[CrossRef][Medline] [Order article via Infotrieve]
  52. Bowmaker, M., Yang, M. Y., Yasukawa, T., Reyes, A., Jacobs, H. T., Huberman, J. A., and Holt, I. J. (2003) J. Biol. Chem. 278, 50961–50969[Abstract/Free Full Text]
  53. Yang, M. Y., Bowmaker, M., Reyes, A., Vergani, L., Angeli, P., Gringeri, E., Jacobs, H. T., and Holt, I. J. (2002) Cell 111, 495–505[CrossRef][Medline] [Order article via Infotrieve]
  54. Takamatsu, C., Umeda, S., Ohsato, T., Ohno, T., Abe, Y., Fukuoh, A., Shinagawa, H., Hamasaki, N., and Kang, D. (2002) EMBO Rep. 3, 451–456[CrossRef][Medline] [Order article via Infotrieve]
  55. Parisi, M. A., Xu, B., and Clayton, D. A. (1993) Mol. Cell. Biol. 13, 1951–1961[Abstract/Free Full Text]

Add to CiteULike CiteULike   Add to Complore Complore   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?


This article has been cited by other articles:


Home page
Am. J. Pathol.Home page
G. S. Shadel
Expression and Maintenance of Mitochondrial DNA: New Insights into Human Disease Pathology
Am. J. Pathol., June 1, 2008; 172(6): 1445 - 1456.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
C. Adan, Y. Matsushima, R. Hernandez-Sierra, R. Marco-Ferreres, M. A. Fernandez-Moreno, E. Gonzalez-Vioque, M. Calleja, J. J. Aragon, L. S. Kaguni, and R. Garesse
Mitochondrial Transcription Factor B2 Is Essential for Metabolic Function in Drosophila melanogaster Development
J. Biol. Chem., May 2, 2008; 283(18): 12333 - 12342.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
K. Vercauteren, N. Gleyzer, and R. C. Scarpulla
PGC-1-related Coactivator Complexes with HCF-1 and NRF-2{beta} in Mediating NRF-2(GABP)-dependent Respiratory Gene Expression
J. Biol. Chem., May 2, 2008; 283(18): 12102 - 12111.
[Abstract] [Full Text] [PDF]


Home page
Physiol. Rev.Home page
R. C. Scarpulla
Transcriptional Paradigms in Mammalian Mitochondrial Biogenesis and Function
Physiol Rev, April 1, 2008; 88(2): 611 - 638.
[Abstract] [Full Text] [PDF]


Home page
Nucleic Acids ResHome page
J. Cotney, Z. Wang, and G. S. Shadel
Relative abundance of the human mitochondrial transcription system and distinct roles for h-mtTFB1 and h-mtTFB2 in mitochondrial biogenesis and gene expression
Nucleic Acids Res., June 18, 2007; (2007) gkm424v2.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
Y. Matsushima and L. S. Kaguni
Differential Phenotypes of Active Site and Human Autosomal Dominant Progressive External Ophthalmoplegia Mutations in Drosophila Mitochondrial DNA Helicase Expressed in Schneider Cells
J. Biol. Chem., March 30, 2007; 282(13): 9436 - 9444.
[Abstract] [Full Text] [PDF]


Home page
Nucleic Acids ResHome page
M. Roberti, F. Bruni, P. L. Polosa, M. N. Gadaleta, and P. Cantatore
The Drosophila termination factor DmTTF regulates in vivo mitochondrial transcription
Nucleic Acids Res., May 3, 2006; 34(7): 2109 - 2116.
[Abstract] [Full Text] [PDF]


Home page
Mol. Biol. CellHome page
S. D. Taylor, H. Zhang, J. S. Eaton, M. S. Rodeheffer, M. A. Lebedeva, T. W. O'Rourke, W. Siede, and G. S. Shadel
The Conserved Mec1/Rad53 Nuclear Checkpoint Pathway Regulates Mitochondrial DNA Copy Number in Saccharomyces cerevisiae
Mol. Biol. Cell, June 1, 2005; 16(6): 3010 - 3018.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
Y. Matsushima, C. Adan, R. Garesse, and L. S. Kaguni
Drosophila Mitochondrial Transcription Factor B1 Modulates Mitochondrial Translation but Not Transcription or DNA Copy Number in Schneider Cells
J. Biol. Chem., April 29, 2005; 280(17): 16815 - 16820.
[Abstract] [Full Text] [PDF]


Home page
Hum Mol GenetHome page
H. Tyynismaa, H. Sembongi, M. Bokori-Brown, C. Granycome, N. Ashley, J. Poulton, A. Jalanko, J. N. Spelbrink, I. J. Holt, and A. Suomalainen
Twinkle helicase is essential for mtDNA maintenance and regulates mtDNA copy number
Hum. Mol. Genet., December 15, 2004; 13(24): 3219 - 3227.
[Abstract] [Full Text] [PDF]


This Article
Right arrow Abstract Freely available
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
279/26/26900    most recent
M401643200v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted